KRYS Short Volume

Krystal Biotech, Inc. (KRYS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $9.21B, listed on NASDAQ, employing roughly 275 people, carrying a beta of 0.49 to the broader market. Krystal Biotech, Inc. Led by Krish S. Krishnan, public since 2017-09-20.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
86.6K
Total Volume
102.2K
Short %
84.77%
30-Day Avg Short %
72.71%

Showing 30 days of FINRA short volume data for Krystal Biotech, Inc..

Learn how short volume is reported and how to read the data →

KRYS most-active contracts

TypeStrikeExpirationVolumeOIIVBidAsk
CALL$310.00Jun 18, 2026178737.6%$12.50$15.70
CALL$320.00Aug 21, 2026076243.8%$22.80$26.50

Top 2 contracts from the ORATS-sourced nightly scan; ranked by volume within the broader S&P 500/400/600 + ETF universe.

Frequently asked KRYS short volume questions

What is the daily KRYS short volume?
As of May 15, 2026, Krystal Biotech, Inc. (KRYS) short volume is 86.6K shares against 102.2K total reported volume, or 84.77% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is KRYS short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does KRYS short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.